1. News | 2021.05.31

    Diphtheria outbreak in Yemen: an epidemiology study

    Diphtheria is a severe infection caused in humans by toxigenic strains of Corynebacterium diphtheriae bacteria. If left untreated, it leads to death in 5 to 25% of cases. It generally affects the upper respiratory tracts, causing pseudomembrane formation and sometimes leading to suffocation. The infection can be complicated by systemic symptoms caused by the diphtheria toxin. Scientists from the...

  2. Article | 2020.08.13

    The Institut Pasteur Innovation Accelerator

    The main challenge for academics in the commercialization of important new discoveries is the technological development gap: the phase between inventions at an early stage and the stage that innovative technologies must reach to become viable and attractive candidates for licensing and commercialization.For high risk/high value products or for products with low commercial profitability, it is...

  3. Article | 2017.08.08

    General Recommendations

    VACCINATIONSBefore traveling abroad, a vaccination schedule should be drawn up based on two criteria:Administrative obligation: the measures adopted by the country to protect against an infectious risk from another country, rather than the actual risks for the traveler.The actual risks for the traveler: these vary depending on the health situation of the country they are going to, the...

  4. Document de presse | 2004.03.17

    World Tuberculosis Day (March 24): The Institut Pasteur engaged in the fight

    With a third of the world's population infected, 2 million deaths and 8.5 million new cases each year, tuberculosis (TB) is the number two infectious disease in the world after AIDS, without sparing France, where 6300 new cases occurred last year. The prevalence of the resistance to antibiotics and the emergence of multiresistance are worrying at the international level, and is a risk for...

  5. Document de presse | 2012.04.18

    A new hope in the fight against tuberculosis

    Researchers from the Institut Pasteur and Inserm, in collaboration with researchers from the University of Pisa, have uncovered the key role played by specific proteins in the virulence of the mycobacterium responsible for tuberculosis, Mycobacterium tuberculosis. They were able to create an attenuated strain of the mycobacterium, which confers a better protection against tuberculosis than the...

  6. News | 2023.12.19

    Tick-borne viruses evade innate immunity

    Flaviviruses are pathogens transmitted by ticks that can cause serious diseases including neurological disorders. A study conducted at the Institut Pasteur reveals how these viruses can slip between the cracks of immunity.

  7. Événement | 2022.10.28

    A bicentenary tribute to Louis Pasteur, Foreign Member of the Royal Society

    To celebrate the bicentenary of Louis Pasteur's birth and pay tribute to this scientist who was a Foreign Member of the Royal Society, the Institut Pasteur and the Académie des sciences are organizing a symposium with support from the Royal Society. This symposium will present cutting-edge research in Louis Pasteur’s own research areas and promote international cooperation in science and...

  8. News | 2022.11.24

    From bacterial poisons to toxins: the early work of the Pasteurians

    Jean-Marc Cavaillon, Honorary Professor at the Institut Pasteur, presents an overview of the discoveries that have shaped our understanding of bacterial toxins.

  9. News | 2024.12.09

    Lessons learned from the COVID-19 crisis: improving protection through early response, rapid tracking and impact monitoring

    Scientific experts from 13 Western European countries have recently completed a review of key lessons learned from the way the COVID-19 pandemic was handled. Two key findings have emerged. Firstly, death rates were lower in countries that took measures early. Secondly, the need for a surveillance system capable of quickly tracking the community spread of a virus and its impact on hospitals was...

  10. Article | 2025.07.09

    Virology

    Fighting viral infections that affect human health.

Pages

Back to top